A continuous fluorometric assay for phospholipase A2 activity in brain cytosol

Alterations in phospholipase A₂ (PLA₂) activity have been implicated in Alzheimer disease and other neurological disorders, although brain PLA₂ activity is currently measured using lengthy, non-continuous assays. We describe herein a rapid, continuous assay in which we measured PLA₂ activity in mouse brain cytosol (CB-57). Brains were homogenized in HEPES buffer (pH 7.5) and the cytosolic fraction was prepared by centrifugation at 25 000×g for 20 min, followed by centrifugation of the supernatant at 100 000×g for 60 min. Cytosolic protein content was determined using the Bradford assay. Pyrene labeled phosphatidylcholine was added to 50 μg of cytosolic protein in Tris buffer (pH 8.0) containing fatty acid free-bovine serum albumin for a final assay volume of 2 ml. Assay temperature was maintained at 30±1°C. The excitation wavelength was 345 nm and emission was measured at 377 nm. Fluorescence intensity was converted to molar concentrations using a standard curve. Under these conditions, bromoenol lactone inhibited up to 58% of the PLA₂ activity with an IC₅₀ of 0.5 μM. In a separate experiment, lack of appreciable alternative acylhydrolase activity was verified chromatographically. Using this method, brain PLA₂ activity can be measured in a continuous, rapid, and sensitive manner.